DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ advanced 2.30% to $1.78 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.55% to 15,870.90 and Dow Jones Industrial Average falling 2.48% to 38,170.41.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 86.76% short of its 52-week high of $13.44, which the company reached on May 16th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.35% to $156.92, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ fell 0.45% to $22.04.
Trading volume (505,313) remained 222,677 below its 50-day average volume of 727,990.
Data source: Dow Jones Market Data, FactSet. Data compiled April 21, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 21, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。